ACS Cervical Cancer Screening Guidelines Updates

Health & LifestyleNews
188

Listen to article (english)

Translate to Spanish or other 102 languages!

According to the World Health Organization (WHO), in 2022 cervical cancer was the fourth most common cancer among womenTrusted Source worldwide, with about 660,000 new cases. Image for illustration purposes
According to the World Health Organization (WHO), in 2022 cervical cancer was the fourth most common cancer among womenTrusted Source worldwide, with about 660,000 new cases. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

According to the World Health Organization (WHO), in 2022 cervical cancer was the fourth most common cancer among womenTrusted Source worldwide, with about 660,000 new cases.

Studies project that cervical cancer numbers may jump by almost 57% by 2050. 

- Advertisement -

A Pap test or Pap smear is a preventive test that can help diagnose early signs of cervical cancer. In many instances, your doctor may also co-test you for a sexually transmitted infection (STI) with the human papillomavirus (HPV) during a Pap smear.

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/acs-cervical-cancer-screening-guidelines-updates-what-to-know?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-12-09&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
MD Anderson Unveils Breakthroughs in Blood Cancer Treatment
Next article
Simple Ways to Reduce Inflammation and Protect Your Heart

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -